BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16337860)

  • 21. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
    Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
    Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
    Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
    Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal small cell oncocytoma with pseudorosettes A histomorphologic, immunohistochemical, and molecular genetic study of 10 cases.
    Petersson F; Síma R; Grossmann P; Michal M; Kuroda N; Hora M; Yang X; Kinkor Z; Trivunic S; Zalud R; Sperga M; Jaunmuktane Z; Branžovský J; Ferda J; Hes O
    Hum Pathol; 2011 Nov; 42(11):1751-60. PubMed ID: 21652056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new translocation between chromosomes 6 and 9 helps to establish diagnosis of renal oncocytoma.
    Hudacko R; May M; Aviv H
    Ann Diagn Pathol; 2011 Aug; 15(4):278-81. PubMed ID: 20952287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromophobe renal cell carcinoma showing oncocytoma-like hyalinized and edematous stroma: A case report and review of the literature.
    Sakai Y; Watanabe S; Matsukuma S
    Urol Oncol; 2004; 22(6):461-4. PubMed ID: 15610861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A; Buzogany I; Kovacs G
    Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization.
    Picken MM; Chyna B; Flanigan RC; Lee JM
    Am J Clin Pathol; 2008 Mar; 129(3):377-82. PubMed ID: 18285259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal oncocytoma with t(5;12;11), der(1)1;8) and add(19): "true" oncocytoma or chromophobe adenoma?
    Dijkhuizen T; van den Berg E; Störkel S; de Vries B; van der Veen AY; Wilbrink M; Geurts van Kessel A; de Jong B
    Int J Cancer; 1997 Nov; 73(4):521-4. PubMed ID: 9389566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis.
    Joshi S; Tolkunov D; Aviv H; Hakimi AA; Yao M; Hsieh JJ; Ganesan S; Chan CS; White E
    Cell Rep; 2015 Dec; 13(9):1895-908. PubMed ID: 26655904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
    Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
    Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.
    Blanco L; Larrinaga G; Pérez I; López JI; Gil J; Agirregoitia E; Varona A
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F850-8. PubMed ID: 18216146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal oncocytoma with a translocation t(9;11)(p23;q13).
    Füzesi L; Gunawan B; Braun S; Boeckmann W
    J Urol; 1994 Aug; 152(2 Pt 1):471-2. PubMed ID: 8015093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
    Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
    Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: is this an oncocytic variant of chromophobe renal cell carcinoma?
    Yamaguchi T; Kuroda N; Imamura Y; Hes O; Michal M; Sima R; Nakayama K; Sato N
    Diagn Cytopathol; 2010 Jul; 38(7):509-13. PubMed ID: 19941365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
    Brown JA; Takahashi S; Alcaraz A; Borell TJ; Anderl KL; Qian J; Persons DL; Bostwick DG; Lieber MM; Jenkins RB
    J Urol; 1996 Jul; 156(1):31-5. PubMed ID: 8648831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation.
    Gowrishankar B; Przybycin CG; Ma C; Nandula SV; Rini B; Campbell S; Klein E; Chaganti RS; Magi-Galluzzi C; Houldsworth J
    J Urol; 2015 May; 193(5):1479-85. PubMed ID: 25498568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
    Okoń K; Sińczak-Kuta A
    Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.